Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/ interim statements

08.05.2024 - 08:00:42 | dgap.de

Dermapharm Holding SE / DE000A2GS5D8

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements


08.05.2024 / 08:00 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 1st half-year

Language: German
Date of disclosure: May 15, 2024
Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857

Language: English
Date of disclosure: May 15, 2024
Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876


08.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

1895309  08.05.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1895309&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos
DE000A2GS5D8 | DERMAPHARM HOLDING SE | boerse | 65306045 |